. Characterization of biotin-doped mPpy NWs. The photographs confirm the presence of NW networks generated upon the addition of the NWs to plasma, where DNA ladders (100 bp, 250 ng/mL) were spiked ex vivo into the plasma of three healthy donors. Even after being transferred to PBS solution, the aggregates formed remained intact and were not dispersed. (d) Droplet digital PCR (ddPCR) confirmed that cfDNA extracted from the plasma of patients with lung cancer by using NWs of 18 μm length has the same EGFR 19 mutation as tumor tissue. However, mutation status information could not be obtained from cfDNA extracted with NWs of 3-µm length (data not shown). Figure S3 . Analysis of EGFR L858R mutation of cfDNA isolated from the plasma of a lung cancer patient by directly analyzing cfDNA-NW conjugates (left) and by releasing the DNA from the cfDNA-NW conjugates (right). ddPCR confirmed that both cfDNA in cfDNA-NW conjugates (left) and cfDNA released from the cfDNA-NW conjugates (right) harbor the same EGFR L858R mutation as tumor tissue. Figure S4 . Examination of Ab cocktail/mPpy NWs using artificial blood samples. Quantitative evaluation of recovery efficiencies using artificial blood prepared by ex vivo spiking of (a) EpCAMpositive cells (MCF7 breast cancer) and (b) EpCAM-negative cells (MIA PaCa-2 pancreas cancer) into two different types of solution (PBS and whole blood). (c) Confocal images of cells captured from artificial blood samples and verified by four-color immunofluorescence staining (DNA (blue), CD45 (violet), EpCAM (green), and CD44 (red) (scale bar, 20 µm).
